Over 450,000 Insulin Syringes Recalled Due to Deadly Labeling Error
The Food & Drug Administration has issued a Class 1 recall of 471,000 Covidien ReliOn insulin syringes sold at Wal-Mart & Sam Club's between July and October 2008. The hypodermic syringes have been mislabeled and as a result a patient could receive over double the dose of prescribed insulin. Class 1 recalls are reserved for situations in which continued use of the product could cause serious injury or death.
The syringes affected by the recall are sold under the brand name of ReliOn and are of the 1cc, 31-gauge variety. They are sold in packages of 100 units for use with U-100 insulin. Syringes labeled for use with U-40 unit insulin were placed in packages with syringes labeled for use with U-100 insulin. If a patient was to use a mislabeled syringe they could receive as much as 2.5 times the prescribed dose. The overdose of insulin could lead to hypoglycemia, abnormally low level of blood sugar, which could lead to serious health consequences or death.
Continue reading "Over 450,000 Insulin Syringes Recalled Due to Deadly Labeling Error" »
